Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$39,977,378
-$2,332,103 QoQ
Shares Held
311,108
-11.5% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
#358
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Northwest & Ethical Investments L.P. holds $150,710,322 across 7 Drug Manufacturers - General names. MRK ranks #1 (26.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
This page
|
311,108 | $39,977,378 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
294,685 | $37,230,502 | |
| 3 | LLY |
ELI LILLY & Co
|
27,350 | $32,804,413 | |
| 4 | ABBV |
AbbVie Inc.
|
118,057 | $29,707,863 | |
| 5 | PFE |
Pfizer Inc
|
221,058 | $5,323,076 | |
| 6 | JNJ |
Johnson & Johnson
|
20,023 | $5,085,241 | |
| 7 | BIIB |
Biogen Inc.
|
2,693 | $581,849 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,977,378 | 311,108 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $42,309,481 | 351,729 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $34,593,488 | 328,648 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $25,559,202 | 304,530 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $23,950,649 | 302,560 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $33,722,113 | 375,692 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $29,011,252 | 291,629 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $31,565,705 | 277,965 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $34,381,488 | 277,718 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $36,646,209 | 277,728 | Shares | Sole | 2025-07-09 | |
| 2023-12-31 | $28,940,231 | 265,458 | Shares | Sole | 2025-07-09 | |
| 2023-09-30 | $28,238,052 | 274,289 | Shares | Sole | 2025-07-09 | |
| 2023-06-30 | $31,910,758 | 276,547 | Shares | Sole | 2025-07-09 | |
| 2023-03-31 | $28,069,831 | 263,839 | Shares | Sole | 2025-07-09 | |
| 2022-12-31 | $31,132,348 | 280,598 | Shares | Sole | 2025-07-09 | |
| 2022-09-30 | $18,912,296 | 219,604 | Shares | Sole | 2025-07-09 | |
| 2022-06-30 | $20,125,230 | 220,744 | Shares | Sole | 2025-07-09 | |
| 2022-03-31 | $13,727,785 | 167,310 | Shares | Sole | 2025-07-09 | |
| 2021-12-31 | $16,027,646 | 209,129 | Shares | Sole | 2025-07-09 | |
| 2021-09-30 | $17,986,967 | 239,475 | Shares | Sole | 2025-07-09 | |
| 2021-06-30 | $16,605,683 | 213,523 | Shares | Sole | 2025-07-09 | |
| 2021-03-31 | $19,580,639 | 253,997 | Shares | Sole | 2025-07-09 | |
| 2020-12-31 | $21,087,621 | 257,795 | Shares | Sole | 2025-07-08 | |
| 2020-09-30 | $21,983,170 | 265,017 | Shares | Sole | 2025-07-08 | |
| 2020-06-30 | $18,697,242 | 241,785 | Shares | Sole | 2025-07-08 | |
| 2020-03-31 | $15,287,356 | 198,692 | Shares | Sole | 2025-07-08 | |
| No filing history on record for this holder in this stock. | ||||||